Showing results (1-10 of 312) with videos related to
Sort By:
Pageof 32
Cancer Discovery|January 16, 2013
Unpicking the combination lock for mutant BRAF and RAS melanomasBissan Al-Lazikani, Paul WorkmanNature Biotechnology|July 12, 2012
Combinatorial drug therapy for cancer in the post-genomic eraBissan Al-Lazikani, Udai Banerji, Paul WorkmanCancer Cell|April 21, 2012
Personalized medicine: patient-predictive panel powerPaul Workman, Paul A Clarke, Bissan Al-LazikaniCurrent Opinion in Pharmacology|July 2, 2013
Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncologyPaul Workman, Bissan Al-Lazikani, Paul A ClarkeOncotarget|January 29, 2016
Blocking the survival of the nastiest by HSP90 inhibitionPaul Workman, Paul A Clarke, Bissan Al-LazikaniFuture Medicinal Chemistry|November 29, 2019
Public resources for chemical probes: the journey so far and the road aheadAlbert A Antolin, Paul Workman, Bissan Al-LazikaniPlos Computational Biology|December 25, 2015
Distinctive Behaviors of Druggable Proteins in Cellular NetworksCostas Mitsopoulos, Amanda C Schierz, Paul Workman, et al.Current Pharmaceutical Design|September 28, 2016
Polypharmacology in Precision Oncology: Current Applications and Future ProspectsAlbert A Antolin, Paul Workman, Jordi Mestres, et al.Plos One|May 26, 2017
SiGNet: A signaling network data simulator to enable signaling network inferenceElizabeth A Coker, Costas Mitsopoulos, Paul Workman, et al.Cell Chemical Biology|June 2, 2021
Evolution of kinase polypharmacology across HSP90 drug discoveryAlbert A Antolin, Paul A Clarke, Ian Collins, et al.Pageof 32